 effect glibenclamid myocardi ischem ventricular arrhythmia non-insulin-depend diabet mellitu glibenclamid hypoglycem sulfonylurea blocker adenosin triphosphatase-modul potassium ion channel open channel myocardi cell acut myocardi hypoxia respons ischem ventricular arrhythmia antiarrhythm effect drug non-insulin-depend diabet patient coronari arteri diseas evid holter monitor ventricular prematur complex ventricular tachycardia transient myocardi ischemia patient electrocardiograph monitor number durat myocardi ischem event frequenc ventricular prematur complex ventricular tachycardia minut ischemia percentag ventricular prematur complex total ischem beat patient group group patient metformin placebo group patient glibenclamid fourteenth day patient underw control monitor crossov group new holter monitor sequenc end second phase indic frequenc ventricular prematur complex episod nonsustain ventricular tachycardia transient myocardi ischemia number durat acut myocardi ischem attack spontan ventricular arrhythmia glibenclamid antiarrhythm effect ventricular arrhythmia transient myocardi ischemia